Biotechnology (Science) News | Latest News
The latest news on the science of Biotechnology, from the best sources of Biotechnology news. Get the latest Biotechnology news now.
Source: newsnow.co.uk
Page 9 - Preclinical Data News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Preclinical Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Preclinical Data Today - Breaking & Trending Today
Basilea Pharmaceutica AG: Basilea präsentiert auf ESMO-Kongress vollständige Daten zur Sicherheit und Wirksamkeit von Derazantinib bei Patienten mit FGFR2-Fusions-positivem iCCA
- Progressionsfreies Überleben (PFS) unter Derazantinib-Monotherapie auf acht Monate verlängert Basel, 17. September 2021 Basilea Pharmaceutica AG (SIX: BSLN) gab heute die Veröffentlichung
Source: finanznachrichten.de
Evaxion Biotech Reports Preclinical Proof of Concept Data for Evaxion's AI-powered Vaccine Platform RAVEN for the Design of a Next Generation SARS-CoV-2 Vaccine
COPENHAGEN, Denmark, June 03, 2021 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX), a clinical-stage biotech company developing AI-driven immunotherapies and vaccines to improve the lives of patients with cancer and infectious diseases, announced today new preclinical data from its Adaptive and Intelligent Vaccine for a Rapid Response against Corona Viruses (AICoV) program. The AICoV program aims to potentially develop the next generation of corona virus vaccines, utilizing RAVEN, Evaxion
Source: yahoo.com
Wave Life Sciences Announces Proof-of-Concept Preclinical Data for ADAR Editing Program in Alpha-1 Antitrypsin Deficiency
First proof-of-concept in vivo data for RNA editing using endogenous ADAR enzymes in alpha-1 antitrypsin deficiency ADAR editing resulted in therapeutically meaningful restoration of circulating functional AAT protein Wave’s program in alpha-1 antitrypsin deficiency aims to correct the single base mutation in mRNA derived from the SERPINA1 Z allele, thereby addressing both lung and liver manifestations of the disease CAMBRIDGE, Mass., June 02, 2021 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Na
Source: yahoo.com
Cyclerion Therapeutics Announces Publication of CY6463 Preclinical Data in Frontiers in Pharmacology
Series of preclinical studies demonstrate the therapeutic potential of CY6463, a first-in-class, CNS-penetrant sGC stimulator Oral, once-daily CY6463 is being developed for neurological diseases associated with cognitive impairment CAMBRIDGE, Mass., May 27, 2021 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN) today announced the publication of preclinical data of CY6463 in Frontiers in Pharmacology. Cyclerion is developing CY6463, an oral, first-in-class, central nervous system (CNS)-penetrant sGC stimulator, for neurological diseases associated with cognitive impairment, inclu...
Source: yahoo.com